Novel insight into mechanisms of cholestatic liver injury

被引:206
作者
Woolbright, Benjamin L. [1 ]
Jaeschke, Hartmut [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
基金
美国国家卫生研究院;
关键词
Bile acids; Cholestasis; Apoptosis; Necrosis; Neutrophils; Innate immunity; Bile duct ligation; ACID-INDUCED APOPTOSIS; FARNESOID-X-RECEPTOR; BILE-DUCT LIGATION; NF-KAPPA-B; HEPATIC ISCHEMIA-REPERFUSION; PROTECTS RAT HEPATOCYTES; URSODEOXYCHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; CELL INJURY; PERMEABILITY TRANSITION;
D O I
10.3748/wjg.v18.i36.4985
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Cholestasis results in a buildup of bile acids in serum and in hepatocytes. Early studies into the mechanisms of cholestatic liver injury strongly implicated bile acidinduced apoptosis as the major cause of hepatocellular injury. Recent work has focused both on the role of bile acids in cell signaling as well as the role of sterile inflammation in the pathophysiology. Advances in modern analytical methodology have allowed for more accurate measuring of bile acid concentrations in serum, liver, and bile to very low levels of detection. Interestingly, toxic bile acid levels are seemingly far lower than previously hypothesized. The initial hypothesis has been based largely upon the exposure of mu mol/L concentrations of toxic bile acids and bile salts to primary hepatocytes in cell culture, the possibility that in vivo bile acid concentrations may be far lower than the observed in vitro toxicity has far reaching implications in the mechanism of injury. This review will focus on both how different bile acids and different bile acid concentrations can affect hepatocytes during cholestasis, and additionally provide insight into how these data support recent hypotheses that cholestatic liver injury may not occur through direct bile acid-induced apoptosis, but may involve largely inflammatory cell-mediated liver cell necrosis. (c) 2012 Baishideng. All rights reserved.
引用
收藏
页码:4985 / 4993
页数:9
相关论文
共 103 条
[61]
Fxr-/- mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids [J].
Marschall, HU ;
Wagner, M ;
Bodin, K ;
Zollner, G ;
Fickert, P ;
Gumhold, J ;
Silbert, D ;
Fuchsbichler, A ;
Sjövall, J ;
Trauner, M .
JOURNAL OF LIPID RESEARCH, 2006, 47 (03) :582-592
[62]
NF-κB is activated in cholestasis and functions to reduce liver injury [J].
Miyoshi, H ;
Rust, C ;
Guicciardi, ME ;
Gores, GJ .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (03) :967-975
[63]
Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas [J].
Miyoshi, H ;
Rust, C ;
Roberts, PJ ;
Burgart, LJ ;
Gores, GJ .
GASTROENTEROLOGY, 1999, 117 (03) :669-677
[64]
The BH3-Only Protein Bid Does Not Mediate Death-Receptor-Induced Liver Injury in Obstructive Cholestasis [J].
Nalapareddy, Padmavathi Devi ;
Schuengel, Sven ;
Hong, Ji-Young ;
Manns, Michael P. ;
Jaeschke, Hartmut ;
Vogel, Arndt .
AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (03) :1077-1085
[65]
The Nicotinamide Adenine Dinucleotide Phosphate Oxidase (NOX) Homologues NOX1 and NOX2/gp91phox Mediate Hepatic Fibrosis in Mice [J].
Paik, Yong-Han ;
Iwaisako, Keiko ;
Seki, Ekihiro ;
Inokuchi, Sayaka ;
Schnabl, Bernd ;
Oesterreicher, Christoph H. ;
Kisseleva, Tatiana ;
Brenner, David A. .
HEPATOLOGY, 2011, 53 (05) :1730-1741
[66]
Bile acids: Natural ligands for an orphan nuclear receptor [J].
Parks, DJ ;
Blanchard, SG ;
Bledsoe, RK ;
Chandra, G ;
Consler, TG ;
Kliewer, SA ;
Stimmel, JB ;
Willson, TM ;
Zavacki, AM ;
Moore, DD ;
Lehmann, JM .
SCIENCE, 1999, 284 (5418) :1365-1368
[67]
INCREASES OF INTRACELLULAR MAGNESIUM PROMOTE GLYCODEOXYCHOLATE-INDUCED APOPTOSIS IN RAT HEPATOCYTES [J].
PATEL, T ;
BRONK, SF ;
GORES, GJ .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 94 (06) :2183-2192
[68]
Bile-acid-induced cell injury and protection [J].
Perez, Maria J. ;
Briz, Oscar .
WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (14) :1677-1689
[69]
Chronic cholestatic diseases [J].
Poupon, R ;
Chazouillères, O ;
Poupon, RE .
JOURNAL OF HEPATOLOGY, 2000, 32 :129-140
[70]
A MULTICENTER, CONTROLLED TRIAL OF URSODIOL FOR THE TREATMENT OF PRIMARY BILIARY-CIRRHOSIS [J].
POUPON, RE ;
BALKAU, B ;
ESCHWEGE, E ;
POUPON, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (22) :1548-1554